Suboxone and Pentasa drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Suboxone (buprenorphine hydrochloride; naloxone hydrochloride) and Pentasa (mesalamine). Common drug interactions include abdominal pain among females and confusional state among males.

The phase IV clinical study analyzes what interactions people have when they take Suboxone and Pentasa. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Suboxone?

Suboxone has active ingredients of buprenorphine hydrochloride; naloxone hydrochloride. It is often used in opiate withdrawal. eHealthMe is studying from 31,249 Suboxone users. Check the latest studies of Suboxone.

What is Pentasa?

Pentasa has active ingredients of mesalamine. It is often used in crohn's disease. eHealthMe is studying from 23,325 Pentasa users. Check the latest studies of Pentasa.



On Jul, 19, 2026

13 people who take Suboxone and Pentasa together, and have interactions are studied.

Suboxone and Pentasa drug interactions.

What are the common drug interactions of Suboxone and Pentasa, by gender? *:

female:

  1. Abdominal pain
  2. Alopecia (absence of hair from areas of the body)
  3. Anal fistula
  4. Diarrhoea
  5. Eating disorder
  6. Headache (pain in head)
  7. Nausea (feeling of having an urge to vomit)
  8. Pyrexia (fever)
  9. Rectal abscess (pus in rectum)
  10. Sinusitis (inflammation of sinus)

male:

  1. Confusional state
  2. Depressed level of consciousness
  3. Depression
  4. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  5. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures)
  6. Fatigue (feeling of tiredness)
  7. Hepatitis c
  8. Lyme disease (a bacterial infection that is spread to humans by infected ticks)
  9. Pain
  10. Pharyngeal oedema (abnormal accumulation of fluid in the cavities and intercellular spaces of the pharyngeal)

What are the common drug interactions of Suboxone and Pentasa, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Fatigue (feeling of tiredness)
  2. Abdominal pain
  3. Alopecia (absence of hair from areas of the body)
  4. Anal fistula
  5. Diarrhoea
  6. Eating disorder
  7. Headache (pain in head)
  8. Nausea (feeling of having an urge to vomit)
  9. Pyrexia (fever)
  10. Rectal abscess (pus in rectum)

40-49:

  1. Hepatic failure (liver failure)
  2. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  3. Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
  4. Psychotic disorder
  5. Confusional state
  6. Depressed level of consciousness
  7. Drug level increased
  8. Hallucination (an experience involving the perception of something not present)

50-59:

  1. Facial bones fracture (bone fracture of face)
  2. Fall
  3. Skull fracture
  4. Groin abscess (pus in groin)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Osteomyelitis (infection of bone)
  7. Surgery

60+:

n/a

What are the existing conditions these people have? *

  1. Drug Dependence: 3 people, 23.08%
  2. Diarrhea: 3 people, 23.08%
  3. Dermatitis Exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss): 2 people, 15.38%
  4. Stress And Anxiety: 1 person, 7.69%
  5. Pain: 1 person, 7.69%
  6. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 7.69%
  7. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Suboxone and Pentasa?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Suboxone and Pentasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Suboxone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Pentasa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Suboxone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Pentasa and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on buprenorphine hydrochloride; naloxone hydrochloride and mesalamine (the active ingredients of Suboxone and Pentasa, respectively), and Suboxone and Pentasa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: